Join Growin Stock Community!

Varex imaging corporationVREX.US Overview

US StockHealthcare
(No presentation for VREX)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

VREX AI Insights

VREX Overall Performance

VREX AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

VREX Recent Performance

-1.08%

Varex imaging corporation

0.05%

Avg of Sector

-0.31%

S&P500

VREX PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

VREX Key Information

VREX Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

VREX Profile

Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.

Price of VREX

VREX FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

VREX Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.62
PE Ratio (TTM)
-
Forward PE
17.77
PS Ratio (TTM)
0.65
PB Ratio
1.16
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
34.15%
Net Margin
-7.92%
Revenue Growth (YoY)
4.09%
Profit Growth (YoY)
8.76%
3-Year Revenue Growth
0.64%
3-Year Profit Growth
3.31%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.62
PE Ratio (TTM)
-
Forward PE
17.77
PS Ratio (TTM)
0.65
PB Ratio
1.16
Price-to-FCF
-
Gross Margin
34.15%
Net Margin
-7.92%
Revenue Growth (YoY)
4.09%
Profit Growth (YoY)
8.76%
3-Year Revenue Growth
0.64%
3-Year Profit Growth
3.31%

  • When is VREX's latest earnings report released?

    The most recent financial report for Varex imaging corporation (VREX) covers the period of 2026Q1 and was published on 2026/01/02. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating VREX's short-term business performance and financial health. For the latest updates on VREX's earnings releases, visit this page regularly.

  • What is the operating profit of VREX?

    According to the latest financial report, Varex imaging corporation (VREX) reported an Operating Profit of 15.4M with an Operating Margin of 7.35% this period, representing a growth of 37.5% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is VREX's revenue growth?

    In the latest financial report, Varex imaging corporation (VREX) announced revenue of 209.6M, with a Year-Over-Year growth rate of 4.9%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does VREX have?

    As of the end of the reporting period, Varex imaging corporation (VREX) had total debt of 395.5M, with a debt ratio of 0.36. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does VREX have?

    At the end of the period, Varex imaging corporation (VREX) held Total Cash and Cash Equivalents of 119.5M, accounting for 0.11 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does VREX go with three margins increasing?

    In the latest report, Varex imaging corporation (VREX) achieved the “three margins increasing” benchmark, with a gross margin of 33.3%%, operating margin of 7.35%%, and net margin of 1.1%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess VREX's profit trajectory and future growth potential.

  • Is VREX's EPS continuing to grow?

    According to the past four quarterly reports, Varex imaging corporation (VREX)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.06. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of VREX?

    Varex imaging corporation (VREX)'s Free Cash Flow (FCF) for the period is -26.8M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 605.66% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of VREX?

    The latest valuation data shows Varex imaging corporation (VREX) has a Price-To-Earnings (PE) ratio of -8.76 and a Price/Earnings-To-Growth (PEG) ratio of -0.65. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.